Gram-negative bacteria

See the following -

First Research Programme Identifies Potential Antibiotic Resistance Breakers

Press Release | Antibiotic Research UK | December 1, 2016

Antibiotic Research UK's first research programme finds a number of drugs that can break antibiotic resistance in Gram-negative bacteria. Antibiotic resistant infections are predicted to lead to 10 million deaths per year globally by 2050 at a cost of up to $100 trillion to the world economy. In the UK at least 5,000 people per year die from resistant infections. New research by Antibiotic Research UK (ANTRUK), the world's first charity created to develop new antibiotics in the fight against superbugs, has found Antibiotic Resistance Breakers (ARBs) in its first major lab research programme...

Read More »

How We Could Kill Superbugs Without Antibiotics

Charlie Sorrel | Co.Exist | March 1, 2016

Antibiotics will soon be useless, but U.K. scientists have come up with a new way to kill bacteria—and it's not with a drug. And perhaps the best thing about this approach is that bacteria may not be able to build resistance against it. A team from the University of East Anglia, publishing in the journal Nature, figured out that the key to destroying bacteria is understanding how they build their defensive walls. It’s like ruining an astronaut’s space suit instead of going after the astronauts inside...

Read More »

Killing Superbugs with Star-Shaped Polymers, not Antibiotics

Press Release | Bio21 Institute, The University of Melbourne | September 13, 2016

Tiny, star-shaped molecules are effective at killing bacteria that can no longer be killed by current antibiotics, new research shows. The study, published today in Nature Microbiology, holds promise for a new treatment method against antibiotic-resistant bacteria (commonly known as superbugs). The star-shaped structures, are short chains of proteins called ‘peptide polymers’, and were created by a team from the Melbourne School of Engineering...

Read More »

Pfizer Unveils ATLAS®, An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries

Press Release | Pfizer Inc. | April 21, 2017

Pfizer Inc. today announced the launch of the company’s Antimicrobial Testing Leadership and Surveillance (ATLAS) website, which is designed to provide physicians and the global health community with easy access to critical data on the efficacy of various antibiotic treatments and emerging resistance patterns across more than 60 countries. Understanding evolving bacterial resistance patterns is a key element in managing the rise of antimicrobial resistance. To that end, ATLAS can not only help physicians select the most appropriate treatment choices for their patients, but also enable global health authorities to develop data-driven antimicrobial resistance mitigation strategies...

Read More »

Scientists Have Figured Out Why Drug-Resistant 'Superbugs' Are So Hard to Kill

David Nield | Science Alert | February 26, 2016

You may have already heard about the growing problem caused by antibiotic resistance - the spread of superbugs that have evolved to become resistant to the antibiotics we usually attack them with. It's an issue that could have very serious implications for global health and disease if it isn't tackled urgently, and now researchers have made an important step in finding a solution. A new study has discovered how these drug-resistant bacterial cells maintain a defensive barrier, and if further research can find a way to bring down these walls - rather than targeting the bacteria directly - the bacteria could be prevented from developing drug resistance in the first place...

Read More »

Study Identifies a Way to Prevent Burn Injury Infection – Without Antibiotics

Press Release | UT Southwestern Medical Center | December 20, 2016

A new way to fight multidrug-resistant bacteria by blinding them rather than killing them proved highly effective in a model of burn injuries, UT Southwestern Medical Center research shows. “In the United States, there are more than 1 million burn injuries and 100,000 hospitalizations annually. Up to 75 percent of the mortality in burn patients is associated with infections, which are particularly common in patients who suffer extensive burns – those that cover 40 percent or more of the body,” said Dr. Steven Wolf, Section Chief for Burns and Professor of Surgery at UT Southwestern Medical Center...

Read More »

UEA Scientists Pave Way for New Generation of Superbug Drugs

Press Release | University of East Anglia | February 22, 2016

New research published today in the journal Nature reveals the mechanism by which drug-resistant bacterial cells maintain a defensive barrier. The findings pave the way for a new wave of drugs that kill superbugs by bringing down their defensive walls rather than attacking the bacteria itself. It means that in future, bacteria may not develop drug-resistance at all. Unravelling this mechanism could also help scientists understand more about human cell dysfunctions linked to disorders such as diabetes, Parkinson’s and other neurodegenerative diseases...

Read More »